Bulking Agents for Stress Incontinence: Are They a Real Option?
- 169 Downloads
Urethral bulking agents are used in the treatment of female stress urinary incontinence in a wide variety of patients. Numerous materials have been approved for use in the USA, each with inherent properties that can affect its efficacy and safety profile, but none with characteristics deemed ideal to be used as an injectable implant. Few comparative studies are available to clearly define superiority of one agent over another. Nevertheless, bulking agents have demonstrated efficacy in appropriately selected and informed patients and do represent a viable option for women who do not want more invasive therapy and who understand efficacy and duration are inferior to other surgical options.
KeywordsFemale Stress urinary incontinence Bulking agent Collagen
Compliance with Ethics Guidelines
Conflict of Interest
Stephen Mock and W. Stuart Reynolds declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 5.•Dmochowski RR, Blaivas JG, Gormley A, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010;183:1906–14. A good summary of efficacy and adverse events of the surgical modalities for the treatment of female SUI based on a meta-analysis of the available literature.CrossRefPubMedGoogle Scholar
- 11.Lucas MG, Bedretdinova D, Bosch JLHR, et al. Guidelines on urinary incontinence. © European Association of Urology (EAU). Urinary Incontinence-Update March 2013.Google Scholar
- 12.Appell RA, McGuire EJ, DeRidder PA, et al. Summary of effectiveness and safety in the prospective, open, multicenter investigation of Contigen implant for incontinence due to intrinsic sphincteric deficiency in females. J Urol. 1994;151:418A.Google Scholar
- 13.Striker P, Haylen B. Injectable collagen for type 3 female stress incontinence: the first 50 Australian patients. Med J Aust. 1993;158:89–91.Google Scholar
- 14.Swami SK, Eckford SD, Abrams P. Collagen injections for female stress incontinence: conclusions of a multistage analysis and results. J Urol. 1994;151:479A.Google Scholar
- 17.Beavan A: Material properties and applications of Pyrolite® carbon. Materials Engineering 1990.Google Scholar
- 18.Appell RA. Collagen injection therapy for urinary incontinence. Urol Clin N Am. 1994;21:177–82.Google Scholar
- 22.23 Hurtado EA, Appell, RA. Surgery for stress urinary incontinence: minimally invasive procedures. In Badlani GH, Davila GW, Michel MC, de la Rosette J Continence. Springer London 2009, pp 149–164.Google Scholar
- 34.•Herschorn S. Injection therapy for urinary incontinence. In Wein A, Kavoussi LR, Novick AC (10th edition) Campbell-Walsh urology. Philadelphia: Saunders Elsevier 2012, pp2168-85. This chapter from the definitive textbook of Urology provides an in depth background and review of bulking therapy for female SUI. Google Scholar
- 37.Christensen LH, Nielsen JB, Mouritsen L, et al. Tissue integration of polyacryamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig. Dermatol Surg, Suppl. 2008;34:S68.Google Scholar
- 39.•Sokol ER, Karram MM, Dmochowski R. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, mulitcenter North American Study. J Urol. 2014;192:843–9. A large RCT on the newest available bulking agent and whose study criteria included nearly one third of patients who were still symptomatic after other incontinence procedures.CrossRefPubMedGoogle Scholar
- 43.•Peters KM, Dmochowski RR, Carr LK, et al. Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol. 2014;192:469–76. This paper describes a novel therapy whose mechanism of action differs from traditional bulking agents and which has the potential to change the landscape of urethral bulking therapy.CrossRefPubMedGoogle Scholar